Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Payables (2016 - 2025)

Nephros (NEPH) has 16 years of Payables data on record, last reported at $936000.0 in Q3 2025.

  • For Q3 2025, Payables rose 135.18% year-over-year to $936000.0; the TTM value through Sep 2025 reached $936000.0, up 135.18%, while the annual FY2024 figure was $649000.0, 25.66% down from the prior year.
  • Payables reached $936000.0 in Q3 2025 per NEPH's latest filing, up from $632000.0 in the prior quarter.
  • Across five years, Payables topped out at $1.4 million in Q2 2022 and bottomed at $302000.0 in Q2 2023.
  • Average Payables over 5 years is $817947.4, with a median of $779000.0 recorded in 2022.
  • Peak YoY movement for Payables: skyrocketed 1861.76% in 2021, then tumbled 78.6% in 2023.
  • A 5-year view of Payables shows it stood at $1.3 million in 2021, then tumbled by 44.53% to $740000.0 in 2022, then increased by 17.97% to $873000.0 in 2023, then dropped by 25.66% to $649000.0 in 2024, then skyrocketed by 44.22% to $936000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $936000.0 in Q3 2025, $632000.0 in Q2 2025, and $557000.0 in Q1 2025.